TerrAscend Trades Down After Announcing Q3 Results

Terrascend Corp TRSSF, a global cannabis company licensed for sales in Canada, the U.S. and the European Union, released its third-quarter financial report Wednesday. 

Q3 Highlights 

  • Revenue increased from CA$17.6 million ($13.2 million) to CA$26.8 million quarter-over-quarter. 
  • Pro forma revenue for the third quarter of 2019 was about CA$44 million. 
  • The gross profit rose from CA$2.2 million to CA$7 million quarter-over-quarter. 

The company posted an adjusted EBITDA loss fell quarter-over-quarter from CA$8.7 million to CA$6.5 million. 

"I see even greater potential for our business as we sharpen our focus on the U.S., where we are extremely well-positioned to become a leader in the markets we serve," Executive Chairman Jason Ackerman said in a statement.

"My top priority now is to operationalize the company’s strategy while driving continued growth, improving profitability and fortifying our financial strength."

See Also: Decriminalize California, Beckley Foundation Partner In Effort To Legalize Magic Mushrooms In The Golden State

CEO Michael Nashat highlighted the addition of Ilera Healthcare in Pennsylvania to the company's portfolio; the booking of its first international shipment of medical cannabis to Europe; and Health Canada approvals that tripled TerrAscend's licensed space at its Mississauga facility. 

The stock was down 3.3% at $2.63 at the time of publication. 

Photo courtesy of TerrAscend. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisEarningsNewsMarketsIlera Healthcare
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.